List of Achillion Pharmaceuticals patents

Patents where

Current Assignee

Name

Achillion Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10370394 Carbamate, ester, and ketone compounds for treatment of complement mediated disorders	Patent 10370394 was granted and assigned to Achillion Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10370394	August 6, 2019
‌ US Patent 10301336 Phosphonate compounds for treatment of complement mediated disorders	Patent 10301336 was granted and assigned to Achillion Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10301336	May 28, 2019
‌ US Patent 10428094 Amide compounds for treatment of complement mediated disorders	Patent 10428094 was granted and assigned to Achillion Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10428094	October 1, 2019
‌ US Patent 10464956 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders	Patent 10464956 was granted and assigned to Achillion Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10464956	November 5, 2019
‌ US Patent 10253053 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders	Patent 10253053 was granted and assigned to Achillion Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10253053	April 9, 2019
‌ US Patent 10428095 Compounds for treatment of complement mediated disorders	Patent 10428095 was granted and assigned to Achillion Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10428095	October 1, 2019
‌ US Patent 10087203 Compounds for treatment of complement mediated disorders	Patent 10087203 was granted and assigned to Achillion Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10087203	October 2, 2018
‌ US Patent 9732103 Carbamate, ester, and ketone compounds for treatment of complement mediated disorders	Patent 9732103 was granted and assigned to Achillion Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9732103	August 15, 2017
‌ US Patent 9695205 Amide compounds for treatment of complement mediated disorders	Patent 9695205 was granted and assigned to Achillion Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9695205	July 4, 2017
‌ US Patent 10081645 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders	Patent 10081645 was granted and assigned to Achillion Pharmaceuticals on September, 2018 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10081645	September 25, 2018
‌ US Patent 10550140 Ether compounds for treatment of complement mediated disorders	Patent 10550140 was granted and assigned to Achillion Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10550140	February 4, 2020
‌ US Patent 10189869 Amino compounds for treatment of complement mediated disorders	Patent 10189869 was granted and assigned to Achillion Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10189869	January 29, 2019
‌ US Patent 9758537 Compounds for treatment of complement mediated disorders	Patent 9758537 was granted and assigned to Achillion Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9758537	September 12, 2017
‌ US Patent 10100072 Phosphonate compounds for treatment of complement mediated disorders	Patent 10100072 was granted and assigned to Achillion Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10100072	October 16, 2018
‌ US Patent 10005802 Amide compounds for treatment of complement mediated disorders	Patent 10005802 was granted and assigned to Achillion Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10005802	June 26, 2018
‌ US Patent 10385097 Ether compounds for treatment of medical disorders	Patent 10385097 was granted and assigned to Achillion Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10385097	August 20, 2019
‌ US Patent 9796741 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders	Patent 9796741 was granted and assigned to Achillion Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9796741	October 24, 2017
‌ US Patent 9598446 Amino compounds for treatment of complement mediated disorders	Patent 9598446 was granted and assigned to Achillion Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9598446	March 21, 2017
‌ US Patent 9663543 Phosphonate compounds for treatment of complement mediated disorders	Patent 9663543 was granted and assigned to Achillion Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9663543	May 30, 2017
‌ US Patent 9643986 Factor D inhibitors useful for treating inflammatory disorders	Patent 9643986 was granted and assigned to Achillion Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9643986	May 9, 2017
‌ US Patent 9828396 Alkyne compounds for treatment of complement mediated disorders	Patent 9828396 was granted and assigned to Achillion Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9828396	November 28, 2017
‌ US Patent 9732104 Ether compounds for treatment of complement mediated disorders	Patent 9732104 was granted and assigned to Achillion Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	9732104	August 15, 2017
‌ US Patent 10287301 Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders	Patent 10287301 was granted and assigned to Achillion Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10287301	May 14, 2019
‌ US Patent 10011612 Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders	Patent 10011612 was granted and assigned to Achillion Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10011612	July 3, 2018
‌ US Patent 10092584 Compounds for the treatment of medical disorders	Patent 10092584 was granted and assigned to Achillion Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Achillion Pharmaceuticals	Achillion Pharmaceuticals	United States Patent and Trademark Office	10092584	October 9, 2018

Results per page:

82 results

0 selected

82 results

0 selected